Full Text View
Tabular View
No Study Results Posted
Related Studies
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by University of California, Davis.
Recruitment status was  Recruiting
Study NCT00584948   Information provided by University of California, Davis

First Received on December 22, 2007.   Last Updated on June 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fragile X Premutation Carriers
Additional conditions recognized in this trial
Ataxia
Tremor
More general conditions related to this trial
Dyskinesias
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Memantine
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of California, Davis
National Institute on Aging (NIA)
Forest Laboratories


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services